Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
The original version of this Article omitted the following from the end of the Acknowledgements: ‘X.C. also received funding from the Shenzhen Basic Research Program JCYJ20170818140904167.’ This has now been corrected in both the PDF and HTML versions of the Article.
Guardado en:
Autores principales: | Li Zhong, Ying Xu, Rengong Zhuo, Tingting Wang, Kai Wang, Ruizhi Huang, Daxin Wang, Yue Gao, Yifei Zhu, Xuan Sheng, Kai Chen, Na Wang, Lin Zhu, Dan Can, Yuka Marten, Mitsuru Shinohara, Chia-Chen Liu, Dan Du, Hao Sun, Lei Wen, Huaxi Xu, Guojun Bu, Xiao-Fen Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a0493174db748759b5b36fc98777dfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
por: Li Zhong, et al.
Publicado: (2019) -
Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke
por: Ping Li, et al.
Publicado: (2021) -
Author Correction: Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke
por: Ping Li, et al.
Publicado: (2021) -
The Prognostic Value of Serum Soluble TREM-1 on Outcome in Adult Patients with Sepsis
por: Chia-Te Kung, et al.
Publicado: (2021) -
The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
por: So-Hee Park, et al.
Publicado: (2021)